Synergy CHC Corp. (SNYR)
NASDAQ: SNYR · Real-Time Price · USD
1.610
-0.240 (-12.97%)
At close: Apr 25, 2025, 4:00 PM
1.600
-0.010 (-0.62%)
Pre-market: Apr 28, 2025, 4:38 AM EDT

Company Description

Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom.

It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name.

The company also provides hand care products under the Hand MD brand name; beauty products for the eyes, lips, brows, cheeks, and skin under the Perfekt Beauty brand; shapewear, bralettes, and panties under Sneaky Vaunt brand; eyelash enhancement products under The Queen Pegasus brand; topical treatments for neuropathic pain under Neuragen brand; and over-the-counter medications under UrgentRx brand.

It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015.

The company was incorporated in 2010 and is based in Westbrook, Maine.

Synergy CHC Corp.
Country United States
Founded 2010
Industry Medical Distribution
Sector Healthcare
Employees 21
CEO Jack Ross

Contact Details

Address:
865 Spring Street
Westbrook, Maine 04092
United States
Phone 207 321 2350
Website synergychc.com

Stock Details

Ticker Symbol SNYR
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001562733
CUSIP Number 87165D109
ISIN Number US87165D1090
Employer ID 99-0379440
SIC Code 2833

Key Executives

Name Position
Jack Ross Chief Executive Officer and Chairman
Alfred Baumeler President and Director
Jaime Fickett Chief Financial Officer

Latest SEC Filings

Date Type Title
Apr 17, 2025 PRE 14A Other preliminary proxy statements
Mar 31, 2025 10-K Annual Report
Mar 31, 2025 8-K Current Report
Mar 20, 2025 SCHEDULE 13G Filing
Dec 6, 2024 10-Q Quarterly Report
Dec 6, 2024 8-K Current Report
Dec 6, 2024 8-K Current Report
Oct 31, 2024 SC 13D General statement of acquisition of beneficial ownership
Oct 25, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Oct 23, 2024 424B4 Prospectus